Molecular docking and dynamic simulation approach to decipher steroidal sapogenins (genus Trillium) derived agonists for glucocorticoid receptor

References

• Cato, A. C. B., Schacke, H., Sterry, W., & Asadullah, K. (2004). The glucocorticoid receptor as a target for classic and novel anti-inflammatory therapy. Current Drug Target -Inflammation & Allergy, 3(4), 347–353. https://doi.org/10.2174/1568010042634479
   PubMedGoogle Scholar
• Chinnasamy, S., Selvaraj, G., Kaushik, A. C., Kaliamurthi, S., Chandrabose, S., Singh, S. K., Thirugnanasambandam, R., Gu, K., & Wei, D. Q. (2020). Molecular docking and molecular dynamics simulation studies to identify potent AURKA inhibitors: Assessing the performance of density functional theory, MM-GBSA and mass action kinetics calculations. Journal of Biomolecular Structure & Dynamics, 38(14), 4325–4335.
   PubMed Web of Science ®Google Scholar
• De Bosscher, K., & Haegeman, G. (2009). Minireview: Latest perspectives on anti-inflammatory actions of glucocorticoids. Molecular Endocrinology (Baltimore, Md.), 23(3), 281–291.
   PubMed Web of Science ®Google Scholar
• Duma, D., Jewell, C. M., & Cidlowski, J. A. (2006). Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. The Journal of Steroid Biochemistry and Molecular Biology, 102(1–5), 11–21.
   PubMed Web of Science ®Google Scholar
• Fujioka, S., & Sakurai, A. (1997). Biosynthesis and metabolism of brassinosteroids. Physiologia Plantarum, 100(3), 710–715. https://doi.org/10.1111/j.1399-3054.1997.tb03078.x
   Web of Science ®Google Scholar
• Hartmann, M.-A. (1998). Plant sterols and the membrane environment. Trends in Plant Science, 3(5), 170–175.
   Web of Science ®Google Scholar
• Kashyap, K., & Kakkar, R. (2020). An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies. Journal of Biomolecular Structure & Dynamics, 38(1), 48–65.
   PubMed Web of Science ®Google Scholar
• Kauppi, B., Jakob, C., Färnegårdh, M., Yang, J., Ahola, H., Alarcon, M., Calles, K., Engström, O., Harlan, J., Muchmore, S., Ramqvist, A.-K., Thorell, S., Öhman, L., Greer, J., Gustafsson, J.-Å., Carlstedt-Duke, J., & Carlquist, M. (2003). The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. Journal of Biological Chemistry, 278(25), 22748–22754. https://doi.org/10.1074/jbc.M212711200
   PubMed Web of Science ®Google Scholar
• Liu, Y. L., Jang, S., Wang, S. M., Chen, C. H., & Li, F. Y. (2016). Investigation on critical structural motifs of ligands for triggering glucocorticoid receptor nuclear migration through molecular docking simulations. Journal of Biomolecular Structure & Dynamics, 34(6), 1214–1231.
   PubMed Web of Science ®Google Scholar
• Lu, N. Z., Wardell, S. E., Burnstein, K. L., Defranco, D., Fuller, P. J., Giguere, V., Hochberg, R. B., McKay, L., Renoir, J.-M., Weigel, N. L., Wilson, E. M., McDonnell, D. P., & Cidlowski, J. A. (2006). International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: Glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacological Reviews, 58(4), 782–797. https://doi.org/10.1124/pr.58.4.9
   PubMed Web of Science ®Google Scholar
• McMaster, A., & Ray, D. W. (2008). Drug insight: Selective agonists and antagonists of the glucocorticoid receptor. Nature Clinical Practice. Endocrinology & Metabolism, 4(2), 91–101. https://doi.org/10.1038/ncpendmet0745
   PubMedGoogle Scholar
• Meijsing, S. H., Pufall, M. A., So, A. Y., Bates, D. L., Chen, L., & Yamamoto, K. R. (2009). DNA binding site sequence directs glucocorticoid receptor structure and activity. Science (New York, N.Y.), 324(5925), 407–410.
   PubMed Web of Science ®Google Scholar
• Patil, S. S., Bhatt, V., Singh, P. P., & Sharma, U. (2021a). Steroidal sapogenins from Trillium: Chemistry, synthesis, and opportunities in neuro-active steroids designing. Studies Natural Product Chemistry Elsevier, 68, 67–95. https://doi.org/10.1016/B978-0-12-819485-0.00004-9
   Google Scholar
• Patil, S. S., Singh, P. P., Sharma, A., Padwad, Y. S., & Sharma, U. (2021b). Steroidal saponins of Trillium govanianum: Quality control, pharmacokinetic analysis, and anti-inflammatory activity. Biocatalysis and Agricultural Biotechnology, 35, 102071. https://doi.org/10.1016/j.bcab.2021.102071
   Web of Science ®Google Scholar
• Pratt, W. B., & Toft, D. O. (2003). Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Experimental Biology and Medicine (Maywood, N.J.), 228(2), 111–133.
   PubMed Web of Science ®Google Scholar
• Qin, X.-J., Si, Y.-A., Chen, Y., Liu, H., Ni, W., Yan, H., Shu, T., Ji, Y.-H., & Liu, H.-Y. (2017). Cytotoxic steroidal saponins from Trillium kamtschaticum. Bioorganic & Medicinal Chemistry Letters, 27(11), 2267–2273. https://doi.org/10.1016/j.bmcl.2017.04.057
   PubMed Web of Science ®Google Scholar
• Rahman, S. U., Adhikari, A., Ismail, M., Raza Shah, M., Khurram, M., Shahid, M., Ali, F., Haseeb, A., Akbar, F., & Iriti, M. (2016). Beneficial effects of Trillium govanianum rhizomes in pain and inflammation. Molecules, 21(8), 1095. https://doi.org/10.3390/molecules21081095
   PubMed Web of Science ®Google Scholar
• Rahman, S. U., Ismail, M., Khurram, M., Ullah, I., Rabbi, F., & Iriti, M. (2017). Bioactive steroids and saponins of the genus Trillium. Molecules, 22(12), 2156. https://doi.org/10.3390/molecules22122156
   PubMed Web of Science ®Google Scholar
• Rathnayake, S., & Weerasinghe, S. (2018). Exploring the binding properties of agonists interacting with glucocorticoid receptor: An in silico approach. Journal of Molecular Modeling, 24(12), 1–16. https://doi.org/10.1007/s00894-018-3879-1
   Web of Science ®Google Scholar
• Rhen, T., & Cidlowski, J. A. (2005). Anti-inflammatory action of glucocorticoids-new mechanisms for old drugs. New England Journal of Medicine, 353(16), 1711–1723. https://doi.org/10.1056/NEJMra050541
   PubMed Web of Science ®Google Scholar
• Schäcke, H., Döcke, W. D., & Asadullah, K. (2002). Mechanisms involved in the side effects of glucocorticoids. Pharmacology & Therapeutics, 96(1), 23–43. https://doi.org/10.1016/s0163-7258(02)00297-8
   PubMed Web of Science ®Google Scholar
• Schrödinger Release 2020-3. (2020). Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY. Maestro-Desmond Interoperability Tools. Schrödinger.
   Google Scholar
• Singh, P. P., Bora, P. S., Patil, S. S., Bhatt, V., & Sharma, U. (2020a). Qualitative and quantitative determination of steroidal saponins in Trillium govanianum by UHPLC‐QTOF‐MS/MS and UHPLC‐ELSD. Phytochemical Analysis, 31(6), 861–873. https://doi.org/10.1002/pca.2951
   PubMed Web of Science ®Google Scholar
• Singh, P. P., Patil, S. S., Bora, P. S., Bhatt, V., & Sharma, U. (2020b). Govanoside B, a new steroidal saponin from rhizomes of Trillium govanianum. Natural Product Research. https://doi.org/10.1080/14786419.2020.1761360
   Google Scholar
• Tarkowská, D. (2019). Plants are capable of synthesizing animal steroid hormones. Molecules, 24(14), 2585. https://doi.org/10.3390/molecules24142585
   PubMed Web of Science ®Google Scholar
• Wink, M. (2003). Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective. Phytochemistry, 64(1), 3–19. https://doi.org/10.1016/S0031-9422(03)00300-5
   PubMed Web of Science ®Google Scholar
• Wink, M., & Van Wyk, B. E. (2008). Mind-Altering and Poisonous Plants of the World (Vol. 464). Timber Press.
   Google Scholar